GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator
S Inoue, T Mizushima, K Fujita, A Meliti, H Ide… - Human Pathology, 2017 - Elsevier
Immunohistochemistry of a transcription factor, GATA3, has been widely used as a
promising urothelial marker in diagnostic surgical pathology practice. However, the …
promising urothelial marker in diagnostic surgical pathology practice. However, the …
[HTML][HTML] Diagnostic and Prognostic Roles of GATA3 Immunohistochemistry in Urothelial Carcinoma
D Yoo, KW Min, JS Pyo, NY Kim - Medicina, 2023 - mdpi.com
This study aimed to evaluate the diagnostic and prognostic roles of GATA-binding protein 3
(GATA3) immunohistochemistry in urothelial carcinoma (UC) using a meta-analysis. We …
(GATA3) immunohistochemistry in urothelial carcinoma (UC) using a meta-analysis. We …
[HTML][HTML] GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder
H Plage, H Samtleben, S Hofbauer, K Kornienko… - Human pathology, 2022 - Elsevier
The transcription factor GATA binding protein 3 (GATA3) is commonly used in surgical
pathology as a diagnostic marker to distinguish urothelial carcinomas from other cancer …
pathology as a diagnostic marker to distinguish urothelial carcinomas from other cancer …
[HTML][HTML] Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinoma
Aims: This study aims to explore the utility of GATA binding protein 3, a zinc finger
transcription factor, expression in genitourinary carcinoma, especially urothelial carcinoma …
transcription factor, expression in genitourinary carcinoma, especially urothelial carcinoma …
The utility of GATA3 in the diagnosis of urothelial carcinomas with variant morphologic patterns
L Verduin, MJ Mentrikoski, CT Heitz… - … & Molecular Morphology, 2016 - journals.lww.com
The transcription factor GATA3 is a recently described biomarker that is highly expressed in
bladder and breast carcinomas. Although it has shown sensitivity as a marker of primary …
bladder and breast carcinomas. Although it has shown sensitivity as a marker of primary …
GATA3 expression in metastatic urothelial carcinoma in fine needle aspiration cell blocks: A review of 25 cases
MT Siddiqui, S Seydafkan… - Diagnostic Cytopathology, 2014 - Wiley Online Library
GATA binding protein 3 is a zinc finger transcription factor with high affinity for urothelial
tissue and is a promising immunohistochemical marker in detection of urothelial carcinomas …
tissue and is a promising immunohistochemical marker in detection of urothelial carcinomas …
Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms
Transcription factor GATA binding protein 3 (GATA3) has been suggested as a marker of
urothelial carcinoma of the bladder and upper urinary tract. Its expression in primary and …
urothelial carcinoma of the bladder and upper urinary tract. Its expression in primary and …
Differential expression of GATA-3 in urothelial carcinoma variants
Y Liang, J Heitzman, AM Kamat, CP Dinney… - Human pathology, 2014 - Elsevier
Summary GATA binding protein 3 (GATA-3) is a novel immunohistochemical marker for
urothelial carcinoma (UC); however, few studies have investigated GATA-3's role as a …
urothelial carcinoma (UC); however, few studies have investigated GATA-3's role as a …
GATA3 immunohistochemical expression in invasive urothelial carcinoma
KH Mohammed, MT Siddiqui, C Cohen - Urologic Oncology: Seminars and …, 2016 - Elsevier
Introduction GATA binding protein 3 (GATA3) is a transcription factor, which belongs to a
distinct family of tumor suppressor genes. It is involved in human cancer cell growth and …
distinct family of tumor suppressor genes. It is involved in human cancer cell growth and …
Stratification of urothelial bladder carcinoma depending on immunohistochemical expression of GATA3 and CK5/6
MM Serag Eldien, AG Abdou… - … of Immunoassay and …, 2021 - Taylor & Francis
Bladder urothelial carcinoma (BUC) has two pathways with distinct molecular features and
prognosis, non-muscle invasive (NMI) and muscle invasive (MI) tumors. The aim is to …
prognosis, non-muscle invasive (NMI) and muscle invasive (MI) tumors. The aim is to …
相关搜索
- gata3 immunohistochemistry urothelial marker
- gata3 expression urothelial carcinomas
- gata 3 carcinoma variants
- diagnostic utility urothelial carcinoma
- gata 3 differential expression
- regional metastases urothelial carcinomas
- gata3 immunohistochemistry urothelial carcinoma
- utility of gata3 urothelial carcinomas